Annual report pursuant to Section 13 and 15(d)


4 Months Ended
Dec. 31, 2020
USD ($)
Cash flows from operating activities:  
Net income $ 4,092,424
Adjustments to reconcile net loss to net cash used in operating activities:  
Interest earned on treasury securities held in Trust Account (12,473)
Unrealized gain on change in fair value of warrants (5,268,200)
Warrant issuance costs 973,090
Changes in current assets and current liabilities:  
Prepaid assets (315,219)
Accounts payable 96,248
Net cash used in operating activities (434,130)
Cash Flows from Investing Activities:  
Investment held in Trust Account (116,150,000)
Net cash used in investing activities (116,150,000)
Cash flows from financing activities:  
Proceeds from Initial Public Offering, net of underwriters' fees 112,700,000
Proceeds from private placement 5,450,000
Proceeds from issuance of founder shares 25,000
Proceeds from issuance of promissory note to related party 120,000
Repayment of promissory note to related party (120,000)
Payments of offering costs (406,655)
Net cash provided by financing activities 117,768,345
Net Change in Cash 1,184,215
Cash - Beginning 0
Cash - Ending 1,184,215
Supplemental Disclosure of Non-cash Financing Activities:  
Value of common stock subject to possible redemption 96,168,654
Deferred underwriting commissions charged to additional paid-in capital 4,025,000
Initial classification of warrant liability $ 17,640,200